The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of the uterus that produce eggs and important hormones like estrogen and ...

Verastem (VSTM) stock in focus as Jefferies initiates a Buy rating with a $15 target, citing a potential FDA approval for its ovarian cancer drug combo. Read more here.

Health disparities lead to delayed diagnosis of these seven cancer types in the Black community, but awareness and early screening can help save lives.

Research has shed light on how a new type of antibody treatment reactivates patients’ immune cells to fight ovarian cancer.

Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Adding afuresertib to paclitaxel did not improve outcomes in patients with platinum-resistant ovarian cancer in a phase 2 trial.

Researchers from the University of Kentucky Markey Cancer Center have shared encouraging early results from a new clinical ...

Polymer-coated nanoparticles loaded with therapeutic drugs show significant promise for cancer treatment, including ovarian cancer.

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...